AIM ImmunoTech (AIM) FCF Margin Growth (5y) (2015 - 2026)
AIM ImmunoTech (AIM) FCF Margin Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.60 Bn | 130.75 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.93 Bn | 77.93 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.06 Bn | 59.88 Bn | 1.37 Bn |
| 4 | Moderna | 56.22 Bn | 51.08 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.65 Bn | 28.34 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.70 Bn | 9.31 Bn | 668.28 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.48 Bn | - |
| 10 | AIM ImmunoTech | 4.49 Mn | -5.47 Mn | 21,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.02 Mn |
| Mar 31, 2026 | -148,409.00 |
| Dec 31, 2025 | -264,048.00 |
| Sep 30, 2025 | -1.12 Mn |
| Jun 30, 2025 | -293,150.00 |
| Mar 31, 2025 | -751,847.00 |
| Dec 31, 2024 | -421,089.00 |
| Sep 30, 2024 | -470,703.00 |
| Jun 30, 2024 | 372,883.00 |
| Dec 31, 2023 | -1.40 Mn |
| Sep 30, 2023 | -449,668.00 |
| Jun 30, 2023 | 305,281.00 |
| Mar 31, 2023 | -297,092.00 |
| Dec 31, 2022 | -931,750.00 |
| Sep 30, 2022 | -2.15 Mn |
| Jun 30, 2022 | -662,643.00 |
| Mar 31, 2022 | -479,091.00 |
| Dec 31, 2021 | 163,350.00 |
| Sep 30, 2021 | 307,273.00 |
| Jun 30, 2021 | 85,710.00 |